ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 54 filers reported holding ADC THERAPEUTICS SA in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,041,000 | -0.2% | 124,875 | 0.0% | 3.05% | +23.4% |
| Q1 2021 | $3,048,000 | -24.3% | 124,875 | -0.8% | 2.47% | -19.5% |
| Q4 2020 | $4,028,000 | -9.5% | 125,850 | -6.7% | 3.07% | -12.6% |
| Q3 2020 | $4,451,000 | -29.5% | 134,912 | 0.0% | 3.51% | -20.5% |
| Q2 2020 | $6,315,000 | – | 134,912 | – | 4.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |